Learn About the DOMMINO-1 Clinical Trial DOMMINO-1 is a Phase 2 study evaluating inobrodib in combination with pomalidomide and dexamethasone for people living with advanced multiple myeloma who have already received several prior treatments. Researchers are studying whether this treatment approach may benefit patients whose disease has become more difficult to treat. Clinical trials can provide access to investigational therapies while helping advance myeloma research. Learn more about participation: https://clinicaltrials.gov/study/NCT07096778?term=CCS1477-04&rank=1 Email: 📩 clinical@cellcentric.com Call: 📱 +44 1799 531130 #MultipleMyeloma #ClinicalTrials #CancerResearch #HealthTree